Skip to main content
logo
Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
21.78
+0.01 (0.05%)
At close: Aug 1, 2025, 4:00 PM
21.35
-0.43 (-1.97%)
After-hours: Aug 1, 2025, 7:42 PM EDT

Sage Therapeutics Revenue

Neurogene had revenue of $925.00K in the twelve months ending March 31, 2025. In the year 2024, Neurogene had annual revenue of $925.00K.

Revenue (ttm)
$925.00K
Revenue Growth
n/a
P/S Ratio
335.81
Revenue / Employee
$8,645
Employees
107
Market Cap
310.63M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024925.00K--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

NGNE News

More News